Eric L. Cramer is a shareholder at Berger & Montague, P.C., where he has practiced since 1995.  Over the past decade, Mr. Cramer has focused his practice on complex litigation in the antitrust arena, including prosecuting antitrust class actions in the pharmaceutical, medical device, and other major industries.  For his work in antitrust, Mr. Cramer has repeatedly been selected by Chambers USA America’s Leading Lawyers for Business as one of Pennsylvania’s top antitrust lawyers; has been deemed a “Super Lawyer” by Philadelphia Magazine; and was selected as a “Rising Star” and “Antitrust Ace” by Lawdragon.com. In 2006, for instance, Chambers USA noted that he is "a young and extremely smart partner" with a "particularly strong grasp of economic analysis."  In the last several years, Mr. Cramer and his colleagues have won substantial settlements for the clients and class members from pharmaceutical industry defendants for a combined total of more than $970 million in cases involving the following drugs, among others: Cardizem CD, Buspar, Platinol, Terazosin, Relafen, Ovcon, and Remeron.

Mr. Cramer is a Senior Fellow of the American Antitrust Institute and a member of the Board of Public Justice.  He is also a frequent speaker at conferences and symposia on issues involving antitrust, public policy, the pharmaceutical industry, and complex litigation more generally.  Among other writings, Mr. Cramer co-authored an article entitled The Superiority of Direct Proof of Monopoly Power and Anticompetitive Effects in Antitrust Cases Involving Delayed Entry of Generic Drugs, 39 U.S.F. Law Rev. 81 (Fall 2004).

Mr. Cramer is a summa cum laude graduate of Princeton University (1989), where he was elected to Phi Beta Kappa.  He graduated cum laude from Harvard Law School with a J.D. in 1993.  He is admitted to practice in Pennsylvania and New York, and various federal courts. 

Mr. Cramer began his career representing victims of human radiation experimentation carried out by the federal government in conjunction with state and private actors as part of the U.S. atomic weapons program during the Cold War.  He helped resolve two such cases for over $4.7 million combined, and was principally responsible for a reversal by the Ninth Circuit Court of Appeals of a summary judgment dismissal of one of those cases on statute of limitations grounds. See Bibeau, et al. v. Pacific Northwest Research Foundation, et al., 188 F.3d 1105 (9th Cir. 1999).

Mr. Cramer is also active in community affairs, specifically those involving public education. He is a co-founder, and past President of the Board of Trustees of the Independence Charter School, for which he also acted as litigation counsel. After a successful appeal to the Pennsylvania Charter School Appeal Board, which granted the school a charter, Mr. Cramer secured an affirmance by the Commonwealth Court. See School District of Philadelphia v. Independence Charter School, 2001 Pa. Commw. LEXIS 279 (May 3, 2001). The Center City Philadelphia charter school opened its doors to nearly three-hundred elementary age school children in the Fall of 2001 and continues to thrive today. Mr. Cramer also serves on the Board of the Center for Literacy, one of largest non-profit adult literacy organizations in the country, and is Chair of the Board of EducationVotersPA, a non-profit organization dedicated to supporting issues concerning public education in Pennsylvania.